Gilead announces presentation of more than 40 abstracts from extensive liver disease programs at the digital international liver congress™ 2020

Gilead sciences, inc. (nasdaq: gild) announced the presentation of more than 40 abstracts reflecting the breadth of research from the company’s progra
MDGL Ratings Summary
MDGL Quant Ranking